HEALTH● LOWJul 31 · Jul 31, 2026, 5:09 PM
Pfizer Drug Restores Pigment in Late-Stage Vitiligo Trials
Human Progress
“Pfizer said on Thursday its oral drug helped restore skin color in patients with a common form of vitiligo in two late-stage trials… The U.S. drugmaker was testing Litfulo in patients with nonsegmental vitiligo, the most common type of the disease, which causes patches of skin to lose pigment. Pfizer said both studies showed significantly […] The post Pfizer Drug Restores Pigment in Late-Stage Vitiligo Trials appeared first on Human Progress.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH2h agoAbia to distribute over 3 million insecticide-treated netsPremium TimesHEALTH2h agoAbia to distribute over 3 million insecticide-treated netsPremium TimesHEALTH2h agoCould GLP-1 Drugs Help You Live a Longer, Healthier Life?Singularity HubHEALTH2h agoPsychology says that rehearsing everything that could go wrong before a big event is not pessimism, but a documented strategy that works, and those who use it perform just as well as optimists, but only if no one tells them to relaxClarín